SCHEMBL31240407

SCHEMBL31240407

Nc1n[nH]c2ccc(-c3ccnc(Nc4cccc(NC(=O)c5ccccc5)c4)c3)cc12

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 7/20 0.63
▸ JAK1 P23458 4/20 0.63
▸ ULK1 O75385 1/20 0.54
▸ MAPK8 P45983 2/20 0.53
▸ MAPK10 P53779 2/20 0.53
▸ NTRK1 P04629 1/20 0.50
▸ KIT P10721 1/20 0.49
▸ FLT3 P36888 1/20 0.49
▸ AURKA O14965 1/20 0.48
▸ CDK7 P50613 1/20 0.48
▸ KCNK3 O14649 1/20 0.47
▸ KCNK9 Q9NPC2 1/20 0.47
▸ KDR P35968 1/20 0.47
▸ LRRK2 Q5S007 1/20 0.47
▸ CLK2 P49760 1/20 0.46
▸ CLK3 P49761 1/20 0.46
▸ DYRK1A Q13627 1/20 0.46
▸ ITK Q08881 1/20 0.45
▸ PRKD3 O94806 1/20 0.45
▸ ABL1 P00519 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26686431 0.90 JAK2 (0.63) JAK2JAK1ULK1MAPK8MAPK10
SCHEMBL31240484 0.90 JAK2 (0.63) JAK2JAK1ULK1MAPK8MAPK10
SCHEMBL31420124 0.89 JAK2 (0.61) JAK2JAK1ULK1NTRK1KIT
SCHEMBL26686370 0.89 JAK2 (0.61) JAK2JAK1ULK1NTRK1KIT
SCHEMBL31240431 0.88 NPC1 (0.48) JAK2JAK1ULK1MAPK8MAPK10
SCHEMBL31240518 0.87 PIK3C3 (0.48) JAK2JAK1ULK1MAPK8KDR
SCHEMBL31240612 0.86 ROCK1 (0.53) JAK2JAK1ULK1MAPK8LRRK2
SCHEMBL31240611 0.86 ROCK1 (0.53) JAK2JAK1ULK1MAPK8LRRK2
SCHEMBL31240265 0.84 JAK2 (0.61) JAK2JAK1MAPK8MAPK10AURKA
SCHEMBL30633352 0.83 JAK2 (0.56) JAK2JAK1NTRK1KITFLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705291-A1 IKK-ALPHA INHIBITORS Cancer Research Technology Limited (GB) 2026-03-11 — — EP claimed
WO-2024228035-A1 IKK-ALPHA INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-11-07 — — WO claimed
EP-4705291-A1 IKK-ALPHA INHIBITORS Cancer Research Technology Limited (GB) 2026-03-11 — — EP disclosed
WO-2024228035-A1 IKK-ALPHA INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-11-07 — — WO disclosed
Send feedback